Synagis® (palivizumab) is an antibody that helps decrease the risk of serious lung infections caused by Respiratory Syncytial Virus (RSV). See education sheet, "Respiratory Syncytial Virus." Full-term babies get virus-fighting substances called antibodies from their mothers during pregnancy. These antibodies help to fight RSV and other viruses. Babies born prematurely often do not get enough of these antibodies before birth.
This medicine is given only to children under 2 years old at high risk for serious complications if they should get RSV. It is
not a treatment for children who already have RSV. Synagis may be given with routine immunizations.
The doctor will send a referral to a specialty pharmacy (or home care company). The pharmacy or home care will obtain the insurance approval, and then the medicine will be sent to either your home or the doctor's office. If the doctor wants Synagis given at home, a home care nurse will call you to make an appointment to come to your house.
This sheet is not specific to your child, but provides general information. If you have any questions, call the clinic.
Children's Hospitals and Clinics of Minnesota
Minneapolis, MN 55404
Last reviewed 8/2015 ©Copyright
This page is not specific to your child, but provides general information on the topic above. If you have any questions, please call your clinic. For more reading material about this and other health topics, please call or visit Children's Minnesota Family Resource Center library, or visit www.childrensmn.org/educationmaterials.
© 2024 Children's Minnesota